b5media.com

Advertise with us

Enjoying this blog? Check out the rest of the Health & Wellness Channel Subscribe to this Feed

Genetics and Health

Archive for the ‘Breast cancer’ Category

April 23rd, 2008

Gene signature found for breast cancer survival

(Photo: Breast cancer cell , courtesy www.hopeforcancer.com)
Scientists believe they have identified a gene that may be able to limit the growth of breast cancer tumors.
The US National Cancer Institute, led by geneticist Kent Hunter found in tests on mice that tumors containing the bromodomain 4  or Brd4 gene ended up 10 times smaller than ones that did […]

By Elaine -- 0 comments

April 12th, 2008

Navigenics - the whole interview

G&H’s INTERVIEW WITH NAVIGENICS
Navigenics approached Genetics and Health for an interview. With so much written about similar genomics companies such as 23andme, Knome, deCODE genetics, I was intrigued to learn more about this company.  In particular, Navigenics appears to be the only company within this industry genre who provides a comprehensive wellness model – a […]

By Elaine -- 2 comments

April 9th, 2008

Navigenics #4 - “Low penetrance genes v high penetrance genes”

In this fourth in the series of articles originating from G&H’s exlusive interview with Navigenics’ Medical Director Dr Michael Nierenberg, we look at the whole issue of low penetrance versus high penetrance gene testing. 
SNPs are known as ‘low penetrance genes’ where it will only sometimes produce the symptom or trait with which it has been associated […]

By Elaine -- 0 comments

April 9th, 2008

Navigenics #3 - “SNP testing – can it be used for disease risk assessment?”

In this third article originating from G&H’s exclusive interview with Navigenics’ Medical Director, Dr Michael Nierenberg, we explore the whole issue of SNP testing and how SNPs can be used in disease risk assessment.
Navigenics has focused on around 100 of the most definitive research papers on SNPs (single nucleotide polymorphisms) that have been most strongly associated […]

By Elaine -- 2 comments

January 15th, 2008

FDA approves breast cancer genetic test

 
The U.S. Food and Drug Administration (FDA) has approved a test that helps in assessing the risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer. The TOP2A FISH pharmDx is the first approved device to test for the TOP2A (topoisomerase 2 alpha) gene in cancer patients.
The TOP2A gene plays a […]

By Elaine -- 0 comments

Site Meter
Close
E-mail It